Mechanisms of Cbl-Mediated Ubiquitination of Proteins in T and Natural Killer Cells and Effects on Immune Cell Functions
2024
How Cbl Affects Immune Cells and Cancer Treatment
publication
10 minutes
Evidence: high
Author Information
Author(s): Nath Pulak Ranjan, Isakov Noah
Primary Institution: Lentigen Technology Inc.
Hypothesis
Cbl, an E3 ubiquitin ligase, plays a crucial role in regulating T and NK cell functions and may be targeted for cancer immunotherapy.
Conclusion
Cbl-b deficiency enhances T and NK cell responses, making it a promising target for cancer immunotherapy.
Supporting Evidence
- Cbl-b deficiency leads to enhanced T cell activation and anti-tumor immunity.
- Cbl-b regulates the internalization and degradation of T cell receptors.
- Cbl-b is upregulated in exhausted T and NK cells, suggesting a role in immune suppression.
- Targeting Cbl-b may improve the efficacy of CAR T cell therapies.
Takeaway
Cbl helps control how immune cells work, and by changing it, we can make these cells better at fighting cancer.
Methodology
This review discusses the role of Cbl in T and NK cell signaling and its implications for cancer immunotherapy.
Limitations
The review does not provide original experimental data but synthesizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website